Urgotul 99XX0071 Dressing, 5cm x 5cm, Pack of 10

Product Information

Other Single Use Instruments Curettes Needle Holders Probes Stitch Cutters Skin Staple Removers Proctology More... The UrgoTul range is designed to give every acute wound the best chance of healing. Using our Technology Lipido-Colloid (TLC) healing matrix (hydrocolloid particles in a lipophilic substance), UrgoTul dressings: Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-196.

Urgotul Absorb Foam Dressing - MedicalDressings Urgotul Absorb Foam Dressing - MedicalDressings

Acute wounds (burns, dermal abrasions, traumatic wounds, postoperative wounds), chronic wounds (pressure ulcers, diabetic foot ulcers) at the granulation and epithelialisation stage. Couches & Chairs Variable Height Couches 2-Section Couches 3-Section Couches Fixed Height Gynaecology Couches Podiatry Chair Phlebotomy Chairs Prepare the wound according to local protocol. If an antiseptic is first used, rinse the wound thoroughly with saline solution before applying UrgoTul. Ultra-flexible lipido-colloid dressing: Polyester mesh impregnated with TLC: hydocolloid and pharmaceutical grade jelly particles National Institute for Health and Care Excellence (NICE), UrgoStart for treating leg ulcers and diabetic foot ulcers, https://www.nice.org.uk/guidance/mtg42, April 2023

CONFIRMATION

Shown to be effective against bacteria most frequently associated with wound infections: Staphylococcuss aureus, Streptococcuss pyogenes, Pseudomonas aeruginosa (pyocyanic bacillus), MRSA, Enterococcus faecalis VRE, Escherichia coli and Candida albicans (1) UrgoStart must not be used during hyperbaric oxygen chamber therapy without an oxygen mask (risk of combustion due to the presence of fat). This contraindication does not apply for hyperbaric oxygen chamber therapy with an oxygen mask if the oxygen concentration inside the chamber is less than 25% and if UrgoStart is not applied on the area over which the mask is placed. Acute wounds (burns, traumatic wounds, abrasions, post-operative wounds) and chronic wounds (leg ulcers, pressure ulcers and diabetic foot ulcers) at the granulation and epithelialisation stage. The efficacy of TLC-NOSF on the reduction of healing time has been demonstrated in double-blind, randomised controlled clinical studies (3,4,5) and by an analysis of observational studies. (6) The earlier TLC-NOSF treatment is started, the more effective it is. (6)

UrgoTul Absorb Sacrum - Urgo Healthcare Professionals UrgoTul Absorb Sacrum - Urgo Healthcare Professionals

Medical Trolleys Sidhill Surgical Trolleys Sunflower Surgical Trolleys Dressing Trolleys Howarth Storage Trolleys Vista Trolleys Drug Trolleys Cylinder Trolleys In the event of deep, irregular or fistular wounds, leave part of the dressing visible and accessible outside the wound. UrgoTul is a non-occlusive flexible and conformable dressing comprising of a polyester mesh impregnated with Technology Lipido-Colloid (TLC) healing matrix. Urgotul belongs to a new class of non-adherent dressings: the lipidocolloid dressings. It is composed of an open weave polyester mesh impregnated with hydrocolloid polymers dispersed within petrolatum. The first clinical trial data are presented. Efficacy and safety were evaluated in a multicentre non-comparative trial involving 92 patients treated to healing or up to 4 weeks. Adult outpatients with acute wounds (n = 34), leg ulcers (n = 24), other chronic wounds (n = 14) or with second-degree burns (n = 20) were included. Results showed 32.4% (n = 11) of the acute wounds, 12.5% (n = 3) of the leg ulcers and 14.3% (n = 2) of the other chronic wounds completely healed before 4 weeks. Surface areas decreased on average by 76.4%, 63.5% and 44.2% at study endpoint respectively. For burns, 19 patients healed (95%) within 5-19 days. A total of 771 dressing changes were performed during the course of the study. Dressing application was considered as easy or very easy in 90% or more of the changes and there was no difficulty in removing the dressing in about 95% of the cases. Safety was good with five reports of a transitory local adverse event, probably dressing-related, being observed, two patients (2.2%) prematurely stopped treatment because of moderate periwound erythema. Urgotul is a highly promising new dressing which is currently undergoing further comparative clinical evaluation. NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.There are many different wound types, and understanding how best to treat each wound is important. Find out more about taking care of wounds. At each dressing change, nurses were asked to grade the removal of dressing as ‘very easy’, ‘easy’ or ‘difficult’. Overbed Tables EasiRider Overbed Table - Wheelchair Base EasiRider Overbed Table - Standard Base Simple Overbed Table

Urgotul Absorb Border Dressings - Wound Care Urgotul Absorb Border Dressings - Wound Care

C Song, A/Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore The sacrum version is recommended for exuding wounds located in the sacral area (sacral pressure ulcers….).UrgoStart is used in patients with leg ulcers, diabetic foot ulcers and pressure ulcers, from whenever granulation tissue appears until complete healing. In April 2023, we updated section 1 to reflect the current format of NICE guidance. We also added some text to the clinical evidence section to summarise new clinical evidence reviewed. NICE’s recommendations for UrgoStart remain unchanged. More details are in the review decision. New text is marked [2023]. Implementation UrgoClean is indicated for the treatment of exuding wounds in the desloughing phase (chronic wounds and acute wounds).